Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06744907 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
A Phase 4 study of Spinal Fusion, sponsored by Akron Children's Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06744907: Recruiting Phase 4 study of Spinal Fusion, sponsored by Akron Children's Hospital.
NCT06744907 is a Phase 4 study of Spinal Fusion that is actively recruiting participants, run by Akron Children's Hospital. The registered enrollment target is 60 participants, below the 480-participant average among 19 other Spinal Fusion trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06744907, a Phase 4 study of Spinal Fusion, is actively recruiting participants, sponsored by Akron Children's Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
Primary Outcome
1. The skin, along the length of the planned incision 2. The subdermis before application of povidone-iodine versus control with saline 3. The subdermis after application of povidone-iodine versus control with saline) 4. The deep surgical wound after exposure 5. The deep surgical wound after all corrective maneuvers are complete, before closure
Conditions Studied
Interventions
- BIOLOGICAL 10% Povidone-Iodine Arm
- PROCEDURE Saline Arm
Study Locations (1)
Ohio
- Akron Children's Hospital - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2026-11 |
| Phase | Phase 4 |
What NCT06744907 shows while recruiting
NCT06744907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 480-participant average among 19 other Spinal Fusion trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which 10% Povidone-Iodine Arm is the first listed.
NCT06744907 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06744907 about?
NCT06744907 is a clinical study titled "Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion". Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
What is the current status of trial NCT06744907?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2025-01-03. Estimated completion is 2026-11.
What conditions does trial NCT06744907 study?
This clinical trial studies the following conditions: Spinal Fusion.
What interventions are being tested in trial NCT06744907?
The interventions under investigation include: 10% Povidone-Iodine Arm (BIOLOGICAL), Saline Arm (PROCEDURE).
Who is sponsoring clinical trial NCT06744907?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06744907 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06744907's enrollment target sits among peer trials
60 13th of 19 higher than 7 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI